David A. Siegel Catabasis Pharmaceuticals, Inc. Transaction History

Two Sigma Advisers, LP

  • $41.3 Billion
  • Q3 2024

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2021

Nov 15, 2021
SELL
N/A
-36,200 Closed
0 $0
Q2 2021

Aug 16, 2021
SELL
N/A
-49,000 Reduced 57.51%
36,200 $76,000
Q1 2021

May 17, 2021
BUY
N/A
41,400 Added 94.52%
85,200 $246,000
Q4 2020

Feb 16, 2021
BUY
N/A
26,900 Added 159.17%
43,800 $94,000
Q3 2020

Nov 16, 2020
BUY
N/A
16,900 New
16,900 $105,000

About Catabasis Pharmaceuticals, Inc.

CATB Quotes by TradingView
  • Ticker CATB
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 76,948,800
  • Market Cap $657M
More about CATB
Track David A. Siegel's Portfolio

Track David A. Siegel Portfolio

Follow David A. Siegel (Two Sigma Advisers, LP) and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Two Sigma Advisers, LP, based on Form 13F filings with the SEC.

News

Stay updated on Two Sigma Advisers, LP and David A. Siegel with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email